1	This	_	DT	_	_	2	NMOD	_	_
2	study	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	approved	_	JJ	_	_	3	VMOD	_	_
5	by	_	IN	_	_	4	AMOD	_	_
6	the	_	DT	_	_	9	NMOD	_	_
7	Human	_	JJ	_	_	9	NMOD	_	_
8	Research	_	NN	_	_	9	NMOD	_	_
9	Protections	_	NNS	_	_	10	NMOD	_	_
10	Program	_	NN	_	_	5	PMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	the	_	DT	_	_	15	NMOD	_	_
13	Institutional	_	JJ	_	_	15	NMOD	_	_
14	Review	_	NN	_	_	15	NMOD	_	_
15	Board	_	NN	_	_	11	CONJ	_	_
16	.	_	.	_	_	3	P	_	_
		
1	Written	_	VBN	_	_	2	NMOD	_	_
2	consent	_	NN	_	_	8	VMOD	_	_
3	to	_	TO	_	_	2	APPO	_	_
4	participate	_	VB	_	_	3	IM	_	_
5	in	_	IN	_	_	4	VMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	study	_	NN	_	_	5	PMOD	_	_
8	was	_	VBD	_	_	0	ROOT	_	_
9	obtained	_	VBN	_	_	8	VC	_	_
10	from	_	IN	_	_	9	VMOD	_	_
11	all	_	DT	_	_	12	NMOD	_	_
12	volunteers	_	NNS	_	_	10	PMOD	_	_
13	prior	_	JJ	_	_	12	APPO	_	_
14	to	_	TO	_	_	13	AMOD	_	_
15	blood	_	NN	_	_	17	NMOD	_	_
16	donation.Heparinized	_	JJ	_	_	17	NMOD	_	_
17	Vacutainers	_	NNS	_	_	14	PMOD	_	_
18	were	_	VBD	_	_	17	APPO	_	_
19	purchased	_	VBN	_	_	18	VMOD	_	_
20	from	_	IN	_	_	18	VMOD	_	_
21	Becton	_	NNP	_	_	22	NAME	_	_
22	Dickinson	_	NNP	_	_	20	PMOD	_	_
23	(	_	(	_	_	25	P	_	_
24	San	_	NNP	_	_	25	NAME	_	_
25	Jose	_	NNP	_	_	22	PRN	_	_
26	,	_	,	_	_	25	P	_	_
27	CA	_	NN	_	_	25	APPO	_	_
28	)	_	)	_	_	25	P	_	_
29	.	_	.	_	_	8	P	_	_
		
1	1.5-mL	_	NN	_	_	4	NMOD	_	_
2	Eppendorf	_	NN	_	_	4	NMOD	_	_
3	centrifuge	_	NN	_	_	4	NMOD	_	_
4	tubes	_	NNS	_	_	5	VMOD	_	_
5	were	_	VBD	_	_	0	ROOT	_	_
6	purchased	_	VBN	_	_	5	VC	_	_
7	from	_	IN	_	_	6	VMOD	_	_
8	Fisher	_	JJ	_	_	9	NMOD	_	_
9	Scientific	_	JJ	_	_	7	PMOD	_	_
10	(	_	(	_	_	11	P	_	_
11	Pittsburg	_	NNP	_	_	9	PRN	_	_
12	,	_	,	_	_	11	P	_	_
13	PA	_	NN	_	_	11	APPO	_	_
14	)	_	)	_	_	11	P	_	_
15	.	_	.	_	_	5	P	_	_
		
1	Hank	_	NN	_	_	5	NMOD	_	_
2	's	_	POS	_	_	5	SUFFIX	_	_
3	balanced	_	JJ	_	_	5	NMOD	_	_
4	salt	_	NN	_	_	5	NMOD	_	_
5	solution	_	NN	_	_	12	VMOD	_	_
6	(	_	(	_	_	7	P	_	_
7	HBSS	_	NN	_	_	5	PRN	_	_
8	)	_	)	_	_	7	P	_	_
9	and	_	CC	_	_	5	COORD	_	_
10	RPMI	_	NN	_	_	9	CONJ	_	_
11	1640	_	CD	_	_	10	NMOD	_	_
12	were	_	VBD	_	_	0	ROOT	_	_
13	obtained	_	VBN	_	_	12	VC	_	_
14	from	_	IN	_	_	13	VMOD	_	_
15	Irvine	_	NN	_	_	14	PMOD	_	_
16	Scientific	_	JJ	_	_	15	NMOD	_	_
17	(	_	(	_	_	19	P	_	_
18	Santa	_	NN	_	_	19	NMOD	_	_
19	Ana	_	NN	_	_	15	PRN	_	_
20	,	_	,	_	_	19	P	_	_
21	CA	_	NN	_	_	19	APPO	_	_
22	)	_	)	_	_	19	P	_	_
23	.	_	.	_	_	12	P	_	_
		
1	LPS	_	NN	_	_	4	NMOD	_	_
2	fromEscherichia	_	NN	_	_	4	NMOD	_	_
3	coliserotype	_	NN	_	_	4	NMOD	_	_
4	0111:B4	_	NN	_	_	7	VMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	PTX	_	NN	_	_	5	CONJ	_	_
7	were	_	VBD	_	_	0	ROOT	_	_
8	purchased	_	VBN	_	_	7	VC	_	_
9	from	_	IN	_	_	8	VMOD	_	_
10	Sigma	_	NN	_	_	9	PMOD	_	_
11	(	_	(	_	_	13	P	_	_
12	St.	_	NN	_	_	13	NMOD	_	_
13	Louis	_	NN	_	_	10	PRN	_	_
14	,	_	,	_	_	13	P	_	_
15	MO	_	NN	_	_	13	APPO	_	_
16	)	_	)	_	_	13	P	_	_
17	.	_	.	_	_	7	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	PKA	_	NN	_	_	3	NMOD	_	_
3	inhibitor	_	NN	_	_	11	VMOD	_	_
4	,	_	,	_	_	3	P	_	_
5	N-[2-((p-bromocinnamyl)amino)ethyl]-5-isoguinolinesulfonamide-2HCl	_	NN	_	_	3	APPO	_	_
6	]	_	)	_	_	5	P	_	_
7	(	_	(	_	_	8	P	_	_
8	H89	_	NN	_	_	5	PRN	_	_
9	)	_	)	_	_	8	P	_	_
10	,	_	,	_	_	3	P	_	_
11	was	_	VBD	_	_	0	ROOT	_	_
12	purchased	_	VBN	_	_	11	VC	_	_
13	from	_	IN	_	_	12	VMOD	_	_
14	Calbiochem	_	NN	_	_	13	PMOD	_	_
15	(	_	(	_	_	17	P	_	_
16	La	_	NN	_	_	17	NMOD	_	_
17	Jolla	_	NN	_	_	14	PRN	_	_
18	,	_	,	_	_	17	P	_	_
19	CA	_	NN	_	_	17	APPO	_	_
20	)	_	)	_	_	17	P	_	_
21	.	_	.	_	_	11	P	_	_
		
1	Antibodies	_	NNS	_	_	31	VMOD	_	_
2	for	_	IN	_	_	1	NMOD	_	_
3	phosphorylated	_	VBN	_	_	4	NMOD	_	_
4	CREB	_	NN	_	_	2	PMOD	_	_
5	(	_	(	_	_	6	P	_	_
6	serine	_	NN	_	_	1	PRN	_	_
7	133	_	CD	_	_	6	NMOD	_	_
8	)	_	)	_	_	6	P	_	_
9	,	_	,	_	_	1	P	_	_
10	phosphorylated	_	JJ	_	_	11	NMOD	_	_
11	I-kappaBalpha	_	NN	_	_	1	COORD	_	_
12	(	_	(	_	_	13	P	_	_
13	serines	_	NNS	_	_	11	PRN	_	_
14	32	_	CD	_	_	13	NMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	36	_	CD	_	_	15	CONJ	_	_
17	)	_	)	_	_	13	P	_	_
18	,	_	,	_	_	11	P	_	_
19	phosphorylated	_	JJ	_	_	22	NMOD	_	_
20	NF-kappaB	_	NN	_	_	22	NMOD	_	_
21	p65	_	NN	_	_	22	NMOD	_	_
22	subunit	_	NN	_	_	11	COORD	_	_
23	(	_	(	_	_	24	P	_	_
24	serine	_	NN	_	_	22	PRN	_	_
25	276	_	CD	_	_	24	NMOD	_	_
26	)	_	)	_	_	24	P	_	_
27	,	_	,	_	_	22	P	_	_
28	and	_	CC	_	_	22	COORD	_	_
29	secondary	_	JJ	_	_	30	NMOD	_	_
30	antibodies	_	NNS	_	_	28	CONJ	_	_
31	were	_	VBD	_	_	0	ROOT	_	_
32	purchased	_	VBN	_	_	31	VC	_	_
33	from	_	IN	_	_	32	VMOD	_	_
34	Cell	_	NN	_	_	42	NMOD	_	_
35	Signaling	_	NN	_	_	42	NMOD	_	_
36	(	_	(	_	_	39	P	_	_
37	Beverly	_	NNP	_	_	39	NAME	_	_
38	,	_	,	_	_	39	P	_	_
39	MA	_	NNP	_	_	42	PRN	_	_
40	)	_	)	_	_	39	P	_	_
41	.Dextran	_	NN	_	_	42	NMOD	_	_
42	T500	_	NN	_	_	33	PMOD	_	_
43	and	_	CC	_	_	31	COORD	_	_
44	Percoll	_	NN	_	_	45	VMOD	_	_
45	were	_	VBD	_	_	43	CONJ	_	_
46	received	_	VBN	_	_	45	VC	_	_
47	from	_	IN	_	_	46	VMOD	_	_
48	GE	_	NNP	_	_	50	NAME	_	_
49	Healthcare/Amersham	_	NNP	_	_	50	NAME	_	_
50	Biosciences	_	NNP	_	_	47	PMOD	_	_
51	(	_	(	_	_	50	P	_	_
52	Piscataway	_	NNP	_	_	54	NAME	_	_
53	,	_	,	_	_	54	P	_	_
54	NJ	_	NNP	_	_	50	APPO	_	_
55	)	_	)	_	_	50	P	_	_
56	.	_	.	_	_	31	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	enzyme-linked	_	JJ	_	_	4	NMOD	_	_
3	immunosorbent	_	JJ	_	_	4	NMOD	_	_
4	assay	_	NN	_	_	10	VMOD	_	_
5	(	_	(	_	_	6	P	_	_
6	ELISA	_	NN	_	_	4	PRN	_	_
7	)	_	)	_	_	6	P	_	_
8	for	_	IN	_	_	4	NMOD	_	_
9	TNF-alpha	_	NN	_	_	8	PMOD	_	_
10	was	_	VBD	_	_	0	ROOT	_	_
11	obtained	_	VBN	_	_	10	VC	_	_
12	from	_	IN	_	_	11	VMOD	_	_
13	Quantikine	_	NN	_	_	23	NMOD	_	_
14	R	_	NN	_	_	23	NMOD	_	_
15	&	_	NN	_	_	23	NMOD	_	_
16	D	_	NN	_	_	23	NMOD	_	_
17	Systems	_	NNS	_	_	23	NMOD	_	_
18	(	_	(	_	_	23	P	_	_
19	Minneapolis	_	NNP	_	_	23	NMOD	_	_
20	,	_	,	_	_	23	P	_	_
21	MN	_	NN	_	_	23	NMOD	_	_
22	)	_	)	_	_	23	P	_	_
23	.Tris-glycine	_	NN	_	_	12	PMOD	_	_
24	and	_	CC	_	_	10	COORD	_	_
25	DNA	_	NN	_	_	27	NMOD	_	_
26	retardation	_	NN	_	_	27	NMOD	_	_
27	gels	_	NNS	_	_	37	VMOD	_	_
28	,	_	,	_	_	27	P	_	_
29	nitrocellulose	_	NN	_	_	30	NMOD	_	_
30	membranes	_	NNS	_	_	27	COORD	_	_
31	,	_	,	_	_	30	P	_	_
32	and	_	CC	_	_	30	COORD	_	_
33	western	_	NN	_	_	34	NMOD	_	_
34	blot	_	NN	_	_	32	CONJ	_	_
35	running	_	VBG	_	_	27	APPO	_	_
36	buffers	_	NNS	_	_	35	VMOD	_	_
37	were	_	VBD	_	_	24	CONJ	_	_
38	obtained	_	VBN	_	_	37	VC	_	_
39	from	_	IN	_	_	38	VMOD	_	_
40	Invitrogen	_	NNP	_	_	39	PMOD	_	_
41	(	_	(	_	_	42	P	_	_
42	Carlsbad	_	NNP	_	_	40	PRN	_	_
43	,	_	,	_	_	42	P	_	_
44	CA	_	NN	_	_	42	APPO	_	_
45	)	_	)	_	_	42	P	_	_
46	.	_	.	_	_	10	P	_	_
		
1	NE-PER(R)nuclear	_	JJ	_	_	5	NMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	cytoplasmic	_	JJ	_	_	2	CONJ	_	_
4	extraction	_	NN	_	_	5	NMOD	_	_
5	reagents	_	NNS	_	_	26	VMOD	_	_
6	,	_	,	_	_	5	P	_	_
7	the	_	DT	_	_	11	NMOD	_	_
8	BCA	_	NN	_	_	11	NMOD	_	_
9	protein	_	NN	_	_	11	NMOD	_	_
10	reagent	_	NN	_	_	11	NMOD	_	_
11	kit	_	NN	_	_	5	COORD	_	_
12	,	_	,	_	_	11	P	_	_
13	the	_	DT	_	_	18	NMOD	_	_
14	Supersignal	_	NNP	_	_	16	NAME	_	_
15	West	_	NNP	_	_	16	NAME	_	_
16	Pico	_	NNP	_	_	18	NMOD	_	_
17	Chemiluminescent	_	JJ	_	_	18	NMOD	_	_
18	Kit	_	NN	_	_	11	APPO	_	_
19	,	_	,	_	_	11	P	_	_
20	and	_	CC	_	_	11	COORD	_	_
21	the	_	DT	_	_	25	NMOD	_	_
22	LightShift	_	NN	_	_	25	NMOD	_	_
23	Chemiluminescent	_	JJ	_	_	25	NMOD	_	_
24	EMSA	_	NN	_	_	25	NMOD	_	_
25	Kit	_	NN	_	_	20	CONJ	_	_
26	were	_	VBD	_	_	0	ROOT	_	_
27	purchased	_	VBN	_	_	26	VC	_	_
28	from	_	IN	_	_	27	VMOD	_	_
29	Pierce	_	NN	_	_	28	PMOD	_	_
30	(	_	(	_	_	31	P	_	_
31	Rockland	_	NNP	_	_	29	PRN	_	_
32	,	_	,	_	_	31	P	_	_
33	IL	_	NN	_	_	31	COORD	_	_
34	)	_	)	_	_	31	P	_	_
35	.	_	.	_	_	26	P	_	_
		
1	CREB	_	NN	_	_	6	NMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	NF-kappaB	_	NN	_	_	2	CONJ	_	_
4	DNA	_	NN	_	_	6	NMOD	_	_
5	oligonucleotide	_	NN	_	_	6	NMOD	_	_
6	probes	_	NNS	_	_	7	VMOD	_	_
7	were	_	VBD	_	_	0	ROOT	_	_
8	synthesized	_	VBN	_	_	7	VC	_	_
9	by	_	IN	_	_	8	VMOD	_	_
10	IDT	_	NNP	_	_	9	PMOD	_	_
11	(	_	(	_	_	12	P	_	_
12	Coralville	_	NNP	_	_	10	PRN	_	_
13	,	_	,	_	_	12	P	_	_
14	IA	_	NN	_	_	12	APPO	_	_
15	)	_	)	_	_	12	P	_	_
16	.	_	.	_	_	7	P	_	_
		
1	Nylon	_	NN	_	_	2	NMOD	_	_
2	membranes	_	NNS	_	_	3	VMOD	_	_
3	were	_	VBD	_	_	0	ROOT	_	_
4	purchased	_	VBN	_	_	3	VC	_	_
5	from	_	IN	_	_	4	VMOD	_	_
6	Roche	_	NN	_	_	8	NMOD	_	_
7	Applied	_	VBN	_	_	6	AMOD	_	_
8	Sciences	_	NN	_	_	5	PMOD	_	_
9	(	_	(	_	_	10	P	_	_
10	Indianapolis	_	FW	_	_	4	PRN	_	_
11	,	_	,	_	_	10	P	_	_
12	IN	_	IN	_	_	10	COORD	_	_
13	)	_	)	_	_	10	P	_	_
14	.	_	.	_	_	3	P	_	_
		
1	Western	_	NN	_	_	4	NMOD	_	_
2	blot	_	NN	_	_	4	NMOD	_	_
3	band	_	NN	_	_	4	NMOD	_	_
4	quantification	_	NN	_	_	5	VMOD	_	_
5	was	_	VBD	_	_	0	ROOT	_	_
6	performed	_	VBN	_	_	5	VC	_	_
7	with	_	IN	_	_	6	VMOD	_	_
8	the	_	DT	_	_	12	NMOD	_	_
9	UN-SCAN-IT	_	JJ	_	_	12	NMOD	_	_
10	Gel	_	NN	_	_	12	NMOD	_	_
11	Digitizing	_	VBG	_	_	12	NMOD	_	_
12	software	_	NN	_	_	7	PMOD	_	_
13	(	_	(	_	_	19	P	_	_
14	Silk	_	NN	_	_	19	NMOD	_	_
15	Scientific	_	JJ	_	_	19	NMOD	_	_
16	,	_	,	_	_	19	P	_	_
17	Orem	_	NN	_	_	19	NMOD	_	_
18	,	_	,	_	_	19	P	_	_
19	UT	_	NN	_	_	12	PRN	_	_
20	)	_	)	_	_	19	P	_	_
21	.	_	.	_	_	5	P	_	_
		
